ym 022 has been researched along with bromodeoxyuridine in 1 studies
Studies (ym 022) | Trials (ym 022) | Recent Studies (post-2010) (ym 022) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
---|---|---|---|---|---|
65 | 1 | 8 | 13,164 | 71 | 1,816 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukamachi, H; Ichinose, M; Ishihama, S; Kakei, N; Kurokawa, K; Matsushima, M; Miki, K; Shimizu, M; Tatematsu, M; Yahagi, N | 1 |
1 other study(ies) available for ym 022 and bromodeoxyuridine
Article | Year |
---|---|
Effect of CCK-B/gastrin receptor antagonist on pepsinogen-producing cells during omeprazole treatment.
Topics: Animals; Benzodiazepines; Bromodeoxyuridine; Gastric Mucosa; Immunohistochemistry; Male; Omeprazole; Pepsinogens; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; RNA, Messenger; Stomach | 1995 |